7 completed, 2 terminated, 1 withdrawn. 4 Phase 1, 3 Not applicable, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Not applicable | 3 | Completed 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow Stage III Ovarian Germ Cell Tumor: new trials by email Literature Review of Stage III Ovarian Germ Cell Tumor trials Research Report on Stage III Ovarian Germ Cell Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant management of therapy complications, musculoskeletal complications management/prevention - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Not applicable | Withdrawn | Roswell Park Cancer Institute | 2012-05-01 | 2012-07-09 | |
| Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer pUMVC3-hIGFBP-2 multi-epitope plasmid DNA vaccine, laboratory biomarker analysis - Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor | Phase 1 | Completed | University of Washington | 25 | 2012-03-06 | 2021-02-25 |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors temsirolimus, vinorelbine ditartrate - Extensive Stage Small Cell Lung Cancer, Hereditary Paraganglioma | Phase 1 | Completed | University of Southern California | 19 | 2010-06-01 | 2016-06-13 |
| Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) HIPEC Orientation, Consultation with Survivorship Navigator, Questionnaires - Advanced Malignant Mesothelioma, Carcinoma of the Appendix | Not applicable | Completed | Wake Forest University Health Sciences | 10 | 2010-05-01 | 2018-07-03 |
| Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer PD-0332991 - Adult Solid Tumor, Adenocarcinoma of the Colon | Phase 2 | Completed | Abramson Cancer Center at Penn Medicine | 304 | 2009-10-01 | 2021-03-11 |
| Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies stereotactic radiosurgery, quality-of-life assessment - Fallopian Tube Cancer, Ovarian Sarcoma | Phase 2 | Completed | Case Comprehensive Cancer Center | 50 | 2009-05-01 | 2013-11-28 |
| Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors paclitaxel, carboplatin, temsirolimus - Ovarian Sarcoma, Ovarian Stromal Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 38 | 2007-02-01 | 2014-06-19 |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer EF5, motexafin lutetium, pharmacological study - Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix | Not applicable | Terminated | National Cancer Institute (NCI) | 30 | 2004-05-01 | 2013-01-16 |
| Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer imatinib mesylate, therapeutic conventional surgery, laboratory biomarker analysis - Ovarian Dysgerminoma, Recurrent Malignant Testicular Germ Cell Tumor | Phase 2 | Terminated | National Cancer Institute (NCI) | 32 | 2002-06-01 | 2013-01-17 |
| Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer pNGVL3-hICD vaccine, sargramostim, flow cytometry - HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer | Phase 1 | Completed | University of Washington | 66 | 2001-10-01 | 2025-04-06 |
Carcinoma, Ovarian Epithelial (8) · Breast Neoplasms (4) · Colonic Neoplasms (3) · Endometrial Neoplasms (3) · Testicular Neoplasms (3) · Appendiceal Neoplasms (2) · Breast Neoplasms, Male (2) · Carcinoma, Non-Small-Cell Lung (2) · Fallopian Tube Neoplasms (2) · Rectal Neoplasms (2) · Uterine Cervical Neoplasms (2) · Bile Duct Neoplasms (1) · Blast Crisis (1) · Burkitt Lymphoma (1) · Carcinoma, Hepatocellular (1)
Endocrine Gland Neoplasms (10) · Endocrine System Diseases (10) · Genital Diseases (10) · Gonadal Disorders (10) · Neoplasms (10) · Neoplasms by Histologic Type (10) · Neoplasms by Site (10) · Urogenital Diseases (10) · Urogenital Neoplasms (10) · Adnexal Diseases (8) · Carcinoma (8) · Female Urogenital Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (8) · Genital Diseases, Female (8) · Genital Neoplasms, Female (8)
Sirolimus (2) · temsirolimus (2) · Biopsy (1) · Carboplatin (1) · Colony-Stimulating Factors (1) · Flow Cytometry (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1) · Imatinib Mesylate (1) · Immunoenzyme Techniques (1) · Immunologic Techniques (1) · Paclitaxel (1) · Radiosurgery (1) · Referral and Consultation (1) · Surveys and Questionnaires (1) · Taxes (1)
National Cancer Institute (NCI) (3) · University of Washington (2) · Abramson Cancer Center at Penn Medicine (1) · Case Comprehensive Cancer Center (1) · Roswell Park Cancer Institute (1) · University of Southern California (1) · Wake Forest University Health Sciences (1)
United States (8) · Canada (1)
Agustin Garcia (1) · Amit Oza (1) · Christopher Ryan (1) · Mary Disis (1) · Mary L. Disis (1) · Peter ODwyer (1) · Philip McCarthy (1) · Richard McQuellon (1) · Robert DeBernardo, MD (1) · Stephen Michael Hahn (1)
PMID 32641862, PMID 32692450, PMID 36326756
P01CA087971 (1), P30CA015704 (1), U10CA031946 (1)